microrna
mirna
repres
class
small
noncod
rna
sncrna
molecul
regul
mrna
induc
degrad
block
translat
consid
mirna
ubiquit
stabl
conserv
across
anim
speci
seem
feasibl
exploit
clinic
applic
unlik
human
viral
diseas
mirnabas
molecul
progress
clinic
applic
veterinari
medicin
concept
start
come
view
clinic
mirna
could
repres
power
diagnost
tool
pinpoint
anim
viral
diseas
andor
prognost
tool
follow
diseas
progress
remiss
addit
possibl
consequ
mirna
dysregul
make
potenti
therapeut
target
open
possibl
use
tool
gener
viral
diseaseresist
livestock
review
present
updat
preclin
studi
use
sncrna
combat
viral
diseas
affect
pet
farm
anim
moreov
discuss
possibl
challeng
bring
benchbas
discoveri
veterinari
clinic
sncrna
veterinari
infecti
diseas
frontier
veterinari
scienc
wwwfrontiersinorg
mirna
speci
target
mrna
cooper
one
mirna
target
hundr
mrna
speci
multipl
bind
mirna
untransl
region
utr
particular
mrna
lead
either
mrna
degrad
protein
translat
repress
mirna
highli
regul
pattern
degre
express
across
multipl
anim
diseas
target
hundr
host
pathogen
encod
gene
singl
mirna
influenc
gene
network
essenti
develop
progress
diseas
condit
coupl
high
degre
conserv
made
mirna
attract
candid
clinic
applic
combat
pathogen
anim
virus
highli
stabl
use
diseas
biomark
avail
chemic
synthes
mirna
mimic
agonist
vectorbas
rna
interfer
rnai
technolog
rais
idea
therapi
base
noncod
rna
made
feasibl
util
approach
creat
genet
modifi
anim
breed
resist
certain
viral
pathogen
review
summar
current
state
laboratori
studi
gear
toward
clinic
applic
sncrna
mirna
small
interf
rna
sirna
short
hairpin
rna
shrna
diagnos
combat
viral
diseas
affect
anim
veterinari
import
may
thu
impact
anim
human
health
emerg
correl
mirna
express
diseas
pathogenesi
outcom
suggest
potenti
use
mirna
biomark
first
report
describ
role
mirna
diagnost
prognost
marker
human
takamizawa
et
al
demonstr
patient
lung
cancer
lower
level
predict
significantli
wors
prognosi
potenti
cur
resect
intens
use
advanc
genom
technolog
result
rapid
progress
human
person
medicin
biomark
studi
play
central
role
similar
research
interest
emerg
veterinari
medicin
albeit
delay
inde
henri
et
al
report
biomark
studi
veterinari
medicin
still
lag
behind
human
biomark
research
field
veterinari
medicin
focus
health
welfar
farm
companion
anim
well
broader
aspect
biosafeti
animalderiv
food
milk
product
gener
potenti
applic
biomark
veterinari
clinic
includ
diagnosi
stage
prognosi
monitor
respons
therapi
although
sever
wellestablish
biomark
recogn
number
veterinari
viral
diseas
still
mani
barrier
one
exampl
mani
lack
specif
record
use
acut
phase
protein
app
biomark
pig
hors
cattl
suffer
inflammatori
condit
may
infecti
etiolog
footandmouth
diseas
viru
fmdv
infect
porcin
reproduct
respiratori
syndrom
viru
infect
pneumonia
arthriti
enter
postcastr
inflamm
concentr
avail
biomark
molecul
affect
anim
age
thu
need
addit
improv
biomark
anim
diseas
grow
recognit
mirna
may
provid
specif
signatur
reflect
exist
given
clinic
state
regard
result
profil
fluctuat
mirna
express
level
infect
organ
tissu
singl
cell
compar
uninfect
one
throughout
cours
diseas
might
reflect
sever
outcom
diseas
includ
likelihood
respons
given
therapi
biomark
mirna
repres
ideal
candid
owe
biolog
clinic
relev
practic
consist
correl
diseas
activ
biolog
ration
behind
use
mirna
biomark
aris
involv
divers
physiolog
patholog
process
mirna
extrem
practic
mani
advantag
current
use
biomark
instanc
effort
develop
diagnost
differenti
viral
bacteri
infect
typic
requir
differ
intervent
quarantin
versu
feed
antibiot
smaller
number
identifi
mirna
compar
approxim
proteinencod
gene
current
known
impli
comput
approach
deal
mirna
would
simpler
would
requir
fewer
resourc
proteomicsor
mrnabas
approach
anoth
merit
mirna
resist
degrad
ribonucleas
instanc
stabl
formalinfix
paraffinembed
tissu
ffpe
independ
formalin
fixat
time
durat
tissu
block
storag
contrast
mrna
highli
fragment
unstabl
ffpe
problemat
ffpe
avail
sampl
type
long
storag
ffpe
block
led
mrna
degrad
mirna
detect
larg
number
easili
access
sampl
tissu
biopsi
whole
blood
blood
cell
cerebrospin
fluid
saliva
urin
bodi
fluid
circul
mirna
proven
highli
resist
rnase
activ
extrem
ph
temperatur
certainli
mrna
least
part
often
contain
lipid
vesicl
microvesicl
exosom
bound
rnabind
protein
addit
mirna
resist
prolong
exposur
room
temperatur
repeat
freez
thaw
cycl
mirna
may
uniqu
express
specif
bodi
fluid
exemplifi
plasmaserum
tear
breast
milk
semin
fluid
oppos
mirna
protein
much
complex
famili
molecul
due
use
altern
read
frame
splice
variant
variou
posttransl
modif
mani
protein
interest
low
abund
andor
may
display
major
sequenc
variat
among
clinic
relev
speci
order
assess
role
mirna
class
share
biomark
import
investig
crossspeci
conserv
regul
mirna
speci
mirna
famili
annot
mirna
evolutionarili
conserv
among
varieti
organ
particularli
matur
form
figur
sequenc
align
matur
form
among
anim
human
open
box
illustr
high
degre
conserv
seed
region
access
number
accord
mirbas
suggest
major
mirna
constitut
larg
class
predominantli
ortholog
homolog
molecul
exemplifi
crossspeci
variat
mirna
sequenc
typic
observ
nt
peripheri
matur
form
utr
ie
away
highli
conserv
seed
region
figur
uniqu
conserv
pattern
might
attribut
conserv
genom
origin
report
consensu
motif
nt
upstream
downstream
premirna
hairpin
found
conserv
among
nematod
research
slovenia
usa
put
togeth
catalog
describ
integr
assembl
intragen
mirna
host
gene
human
mous
chicken
show
sever
mirna
gene
locat
within
homolog
area
impli
mirna
coloc
coexpress
potenti
coregul
may
conserv
broadli
across
evolut
thu
applic
anim
human
diseas
context
previou
studi
report
canin
mirna
homolog
annot
human
mirna
mirna
cluster
usual
conserv
human
dog
use
next
gener
sequenc
li
et
al
indic
mirna
immun
organ
chicken
duck
conserv
gain
insight
mirna
share
speci
might
use
common
biomark
select
group
mirna
commonli
express
upon
influenza
viru
iav
infect
human
chicken
mirna
analyz
mirview
databas
includ
known
mirna
current
annot
anim
genom
william
pearson
align
program
use
assess
degre
conserv
matur
mirna
two
speci
tabl
percentag
sequenc
ident
confirm
bioedit
sequenc
align
editor
inde
high
degre
conserv
mirna
two
speci
tabl
mirna
sequenc
differ
human
chicken
form
delet
addit
extra
nucleotid
mostli
locat
outsid
seed
region
specul
conserv
mirna
might
promis
candid
univers
biomark
may
help
simultan
pinpoint
given
diseas
state
speci
contrast
nonconserv
mirna
might
least
contributori
role
univers
biomark
may
play
role
speciesspecif
aspect
diseas
pathogenesi
outcom
apart
sequenc
conserv
mirna
presenc
mirna
signatur
human
anim
upon
contract
infecti
diseas
support
concept
common
biomark
taken
togeth
observ
indic
crossspeci
comparison
human
anim
mirna
express
profil
well
conserv
could
provid
uniqu
opportun
exploit
mirna
univers
biomark
also
underlin
common
differ
patholog
diseas
differ
speci
use
mirna
novel
biomark
veterinari
field
repres
promis
concept
come
uniqu
challeng
one
challeng
presenc
mirna
isom
isomir
ie
form
mirna
differ
slightli
annot
matur
sequenc
like
creat
enzymat
addit
adenin
cytidin
uridin
andor
imprecis
cleavag
enzym
dicer
drosha
observ
studi
shown
isomir
regul
upon
infect
henc
biolog
function
meaning
function
overlap
mirna
isom
howev
mirna
annot
tool
ignor
isom
consid
either
nois
sequenc
artifact
presenc
isomir
might
affect
mirna
stabil
repress
capabl
therefor
reduc
valu
biomark
look
mirna
circul
biomark
import
consid
low
mirna
yield
bodi
fluid
plasma
serum
urin
studi
suggest
plasma
contain
higher
mirna
concentr
serum
grow
bodi
evid
indic
use
serum
biolog
sampl
mirna
biomark
studi
might
bias
stress
blood
cell
expos
coagul
result
releas
nucleic
acid
includ
mirna
serum
may
chang
true
repertoir
circul
serum
mirna
give
rise
bias
valu
mind
lack
correl
detect
mirna
plasma
serum
unexpect
prior
centrifug
blood
hemolysi
might
affect
amount
stabil
target
mirna
requir
modif
isol
protocol
moreov
difficulti
mirna
extract
compromis
yield
qualiti
consid
mirna
differenti
express
among
differ
anim
breed
plausibl
mirna
level
may
differ
among
differ
anim
breed
contract
diseas
also
appar
among
human
express
mirna
found
relat
ethnic
regard
receiv
oper
characterist
roc
curv
analysi
indic
predict
onset
breast
cancer
area
curv
auc
african
american
auc
caucasian
hand
best
predictor
caucasian
auc
hold
true
biomark
well
two
report
document
signific
breed
effect
level
plasma
ntprobnp
diagnost
marker
dog
degen
mitral
valv
diseas
dmvd
rna
interfer
form
posttranscript
gene
silenc
function
broad
rang
eukaryot
speci
fight
anim
virus
rnai
mediat
use
sirna
mirna
although
origin
molecul
differ
mirna
endogen
produc
throughout
two
process
step
nucleu
cytoplasm
sirna
exogen
introduc
directli
cytoplasm
doubl
strand
cytoplasm
mirna
sirna
pass
process
step
digest
dicer
enzym
form
duplex
one
strand
duplex
transloc
rnainduc
silenc
complex
risc
mediat
function
sirna
form
perfect
complementar
target
mrna
caus
cleavag
mirna
tend
bind
mrna
target
less
perfectli
lead
repress
translat
histor
laboratorybas
experi
use
rnai
block
replic
anim
virus
start
earli
name
iav
har
mirna
therapeut
use
reli
use
gain
loss
function
link
express
level
mirna
mirna
benefici
viru
upregul
upon
infect
might
block
use
classic
modifi
antimirna
regard
antagomir
cholesterol
conjug
antimirna
use
vitro
vivo
chemic
modifi
nucleotid
lock
nucleic
acid
lna
modif
made
conceiv
design
stabl
specif
oligonucleotid
vivo
system
report
state
effect
use
lna
prove
longlast
safe
neither
toxic
associ
lna
histopatholog
chang
detect
although
attempt
downregul
dicer
drosha
enzym
indirect
way
block
mirna
mechan
strictli
control
sinc
block
enzym
affect
entir
mirna
popul
case
mirna
tend
inhibit
viru
replic
therapeut
approach
could
overexpress
mirna
restor
level
context
synthet
mirna
mimic
resembl
matur
mirna
could
recogn
risc
would
suitabl
tool
vivo
deliveri
mirna
modal
specif
cell
remain
substanti
barrier
use
virus
viruslik
vector
might
innov
approach
sinc
virus
evolv
mani
gener
infect
certain
cell
deliv
foreign
rna
includ
mirna
tissueand
sncrna
veterinari
infecti
diseas
frontier
veterinari
scienc
wwwfrontiersinorg
cellspecif
manner
viral
vector
express
primirna
premirnalik
structur
even
matur
mirna
rna
virus
nuclear
cytoplasm
origin
util
mirna
may
advantag
sirna
therapeut
candid
spite
offtarget
effect
mirna
bind
target
partial
complementar
thu
like
tackl
high
rate
mutat
seen
mani
virus
better
sirna
also
sirna
trigger
interferon
product
part
cellular
stress
respons
pathway
caus
translat
arrest
growth
inhibit
cytotox
contrast
shrna
approach
use
mirna
enabl
express
multipl
mirna
singl
transcript
compar
one
regular
shrna
vector
inde
transfect
cell
two
differ
shrna
may
lead
competit
two
transport
incorpor
risc
result
reduct
shrna
process
activ
despit
report
effici
silenc
gene
use
rnai
differ
efficaci
given
vector
experi
report
might
due
ineffici
cellular
uptak
rnai
may
also
depend
cell
type
follow
overview
updat
vitro
vivo
experi
aim
evalu
potenti
use
small
rna
includ
mirna
treatment
option
viral
diseas
affect
anim
agricultur
andor
econom
import
infect
iav
worldwid
problem
affect
human
anim
health
presenc
multipl
viral
genotyp
possibl
antigen
shift
drift
continu
rais
concern
pandem
potenti
current
influenza
vaccin
therapi
prove
ineffici
combat
continu
evolv
iav
strain
due
occurr
antigen
variat
within
influenza
viru
genom
due
point
mutat
drift
reassort
shift
emerg
resist
viru
strain
ad
anoth
limit
antiiav
therapi
rnai
formul
appropri
agent
would
offer
potenti
new
therapi
target
viral
transcript
furthermor
insert
respons
element
within
genom
creat
attenu
strain
confer
protect
mice
challeng
lethal
strain
suggest
attenu
strain
might
serv
liveattenu
vaccin
around
possibl
sirna
target
site
present
iav
genom
recent
report
describ
use
method
procedur
select
highli
effect
influenzaspecif
sirna
cell
cultur
mice
ferret
use
silico
approach
raza
colleagu
identifi
five
conserv
amino
acid
sequenc
three
hemagglutinin
ha
gene
rglfgaiagfi
ynaellv
aiagfi
two
neuraminidas
n
rtqsec
eecsyp
gene
might
provid
potenti
rnaibas
therapeut
target
variou
iav
strain
rnai
shown
effect
suppress
iav
replic
vitro
vivo
instanc
transfect
mdck
cell
sirna
specif
nucleoprotein
np
nucleotid
posit
polymeras
acid
pa
nucleotid
posit
mrna
sequenc
inhibit
iav
replic
moreov
mixtur
sirna
specif
highli
conserv
region
np
pa
protect
mice
lethal
challeng
iav
subtyp
eg
ref
sirna
matrix
gene
exhibit
similar
slightli
higher
reduct
viru
replic
mdck
cell
human
cell
likewis
iav
titer
mdck
cell
embryon
egg
reduc
respect
shrna
target
polymeras
basic
gene
transfect
vitro
vivo
use
liposomeencapsul
vector
mice
surviv
rate
rang
anoth
experi
sirna
target
region
gene
nucleotid
found
effect
inhibit
protein
translat
cell
line
inhibit
viral
protein
use
sirna
caus
reduct
viral
titer
supernat
sirnatransduc
mdck
cell
hpi
furthermor
viru
bud
abil
reduc
suggest
abil
sirna
target
protein
suppress
iav
replic
anoth
report
demonstr
efficaci
antinp
antipa
shrna
reduc
iav
titer
mdck
cell
avian
chsah
cell
signific
decreas
level
iav
np
mrna
viral
titer
observ
chsah
cell
approach
also
work
well
mdck
cell
demonstr
signific
decreas
level
viral
mrna
iav
infect
titer
furthermor
author
identifi
novel
highli
effici
conserv
rnai
target
site
viral
np
gene
use
antivir
cocktail
shrna
prevent
iav
escap
rnai
silenc
zhou
colleagu
investig
silenc
effect
npspecif
sirna
iav
replic
cell
line
mice
cell
line
reduct
viru
titer
observ
deliveri
significantli
reduc
lung
viru
titer
infect
mice
reduct
titer
partial
protect
lethal
iav
challeng
altern
approach
target
host
cell
gene
crucial
iav
replic
conduct
control
viru
express
aviantyp
humantyp
sialic
acid
sa
receptor
host
tissu
consid
one
host
rang
tissu
tropism
determin
influenza
virus
sirna
duplex
use
inhibit
iav
bind
intern
via
silenc
gene
encod
protein
import
sa
receptor
format
addit
target
cellular
proteas
discuss
method
suppress
iav
replic
roger
colleagu
studi
pulmonari
mirna
express
mice
infect
iav
strain
verifi
furin
member
convertas
famili
mediat
cleavag
hemagglutinin
target
gene
mirna
upon
infect
highlight
import
use
mirna
potenti
therapeut
agent
iav
venezuelan
equin
enceph
viru
veev
belong
genu
alphaviru
famili
togavirida
viru
still
endem
mani
part
world
consid
emerg
diseas
threat
part
well
potenti
biolog
weapon
far
us
food
drug
sncrna
veterinari
infecti
diseas
frontier
veterinari
scienc
wwwfrontiersinorg
administr
fda
approv
drug
vaccin
veev
thu
develop
artifici
mirna
use
control
veev
infect
step
right
direct
inde
veev
target
effici
sirna
recent
shown
target
viral
nonstructur
region
mirna
cell
effici
inhibit
viral
replic
artifici
greatest
effect
studi
indic
artifici
mirna
merit
test
anim
model
antivir
therapi
veev
infect
footandmouth
diseas
fmd
highli
infecti
viral
diseas
usual
affect
clovenhoof
anim
direct
impact
fmd
outbreak
includ
great
loss
agricultur
product
disrupt
local
economi
indirect
effect
lie
diseas
control
measur
local
global
level
high
cost
diseas
control
prevent
program
fmdv
rna
genom
mani
serotyp
target
conserv
viral
gene
major
aim
order
control
fmd
use
peptideconjug
morpholino
oligom
ppmo
mirna
sequenc
complementari
variou
segment
fmdv
genom
effect
block
viral
replic
cell
cultur
model
likewis
dna
vectorbas
rnai
technolog
specif
suppress
express
gene
thu
inhibit
viral
replic
vivo
vitro
use
adenovirusbas
vector
express
sirna
molecul
cell
line
mice
kim
et
al
suggest
appli
rnai
treatment
infect
fmdv
treatment
fmdv
infect
inhibit
viral
replic
effect
combin
treatment
infect
gave
best
result
pig
kidney
cell
cell
suckl
mice
evidenc
lower
viral
titer
cell
line
higher
surviv
rate
treat
mice
experi
reveal
rnai
method
took
consider
time
induc
silenc
effect
rang
h
consid
limit
attempt
control
certain
rapidli
spread
contagi
diseas
includ
fmd
viral
spread
faster
inhibitori
action
rnai
final
use
artifici
mirna
amir
result
specif
silenc
report
gene
fuse
fmdv
target
sequenc
classic
swine
fever
viru
csfv
caus
hemorrhag
diseas
pig
character
dissemin
intravascular
coagul
thrombocytopenia
immunosuppress
csfv
recogn
nearli
year
appear
erad
europ
north
america
due
vaccin
control
measur
first
studi
use
sirna
block
csfv
replic
conduct
three
sirna
molecul
target
differ
region
csfv
npro
gene
prepar
transfect
cell
caus
reduct
viral
genom
copi
number
anoth
studi
synthet
sirna
transfect
swine
kidney
cell
could
target
nucleotid
nucleocapsid
protein
c
csfv
subsequ
reduct
viral
titer
compar
either
mocktreat
nontreat
cell
emphas
potenti
sirna
inhibit
csfv
replic
clearli
vivo
experi
need
conduct
confirm
effect
rabi
zoonot
diseas
caus
rabi
viru
rv
member
rhabidovirida
famili
diseas
typic
infect
canin
usual
transmit
anim
bite
caus
lethal
enceph
annual
number
death
due
rabi
estim
approxim
control
rv
wild
carnivor
move
cull
oper
parenter
oral
vaccin
suscept
speci
inhibit
viral
replic
sirna
mirna
may
anoth
promis
approach
cell
line
use
assess
use
sirna
inhibit
rv
replic
either
use
pool
sirna
singl
multipl
artifici
mirna
target
rv
nucleocapsid
n
vitro
assay
compar
viru
reduct
h
postinfect
especi
singl
mirna
complet
match
target
similar
result
report
other
eg
ref
cultur
cell
murin
model
rv
glycoprotein
prove
essenti
transsynapt
viral
spread
neuron
observ
encourag
research
target
gene
encod
glycoprotein
sonwan
et
al
studi
abil
adenovirusbas
sirna
deliv
cell
inhibit
rv
replic
subsequ
test
approach
mice
studi
sirna
inhibit
viral
replic
cell
line
mice
cell
sirna
target
rv
polymeras
gene
l
gene
found
effect
sirna
target
rv
np
n
gene
inhibit
reduc
rv
replic
specif
reduct
rv
foci
seen
cell
l
gene
target
versu
reduct
n
gene
target
signific
even
greater
differ
observ
mrna
level
reduct
mice
inocul
sirna
vector
result
protect
subsequ
lethal
rv
inject
sirna
simultan
target
glycoprotein
g
n
gene
led
reduct
viral
releas
demonstr
sirna
direct
differ
target
may
act
synergist
increas
efficaci
sirnabas
intervent
rv
taken
togeth
result
suggest
use
sirna
constitut
promis
approach
intervent
rv
viral
infect
fish
aquacultur
devast
costli
earli
report
rnaibas
treatment
describ
use
technolog
fish
shellfish
fish
betanodaviru
two
amino
acid
residu
protein
bind
viral
rna
circumv
rnai
pathway
underscor
import
antivir
role
host
rnai
machineri
dang
studi
sirna
introduc
cell
infect
red
seabream
iridoviru
specif
effect
bound
mrna
encod
viru
major
capsid
protein
lead
reduct
product
viru
particl
supernat
virusinfect
cell
compar
cell
receiv
control
treatment
result
provid
encourag
evid
sirna
technolog
might
use
control
fish
viral
diseas
recent
shrna
construct
found
inhibit
prolifer
viral
hemorrhag
septicemia
viru
target
g
gene
sequencespecif
manner
infect
herpesviru
caus
sever
financi
loss
common
carp
koi
cultur
industri
worldwid
although
investig
employ
vitro
approach
rnai
might
promis
tool
combat
herpesviru
carp
instanc
pool
sirna
specif
dna
enzym
synthesi
capsid
protein
cyprinid
herpesviru
viru
potenti
inhibitor
viru
replic
carp
fibroblast
along
line
gotesman
et
al
demonstr
sirna
inhibit
thymidin
kinas
dna
polymeras
gene
cyprinid
herpesviru
caus
decreas
releas
viral
particl
transfect
common
carp
brain
cell
viral
infect
shrimp
constitut
great
problem
excel
review
discuss
use
rnai
control
variou
viral
infect
shrimp
eg
ref
genet
select
success
mediat
remark
progress
livestock
improv
genet
engin
livestock
commonli
use
produc
pharmaceut
enhanc
product
characterist
anim
also
proven
import
produc
anim
infecti
diseas
resist
exampl
cow
genet
engin
resist
staphylococcu
aureusinduc
mastiti
laboratori
investig
conduct
regard
creat
livestock
furthermor
effort
creat
livestock
resist
gastroenter
coronaviru
infect
publish
studi
limit
work
mice
iav
infect
two
potent
lentivirusbas
shrna
target
np
pa
gene
iav
use
gener
iavresist
mice
howev
success
challeng
experi
report
system
subsequ
studi
base
inhibit
gene
pathogen
conduct
improv
rnai
techniqu
conceiv
genet
engin
diseaseresist
anim
base
sirna
shrna
technolog
may
someday
becom
realiti
veterinari
infecti
diseas
medicin
even
prion
diseas
target
transgenicanim
technolog
featur
shrna
gold
colleagu
attempt
use
sirna
technolog
gener
prionresist
goat
cattl
first
design
lentivirusbas
shrna
tag
green
fluoresc
protein
gfp
direct
caprin
prion
protein
precursor
prp
c
mrna
transfect
vector
adult
goat
fibroblast
cell
line
cell
use
somat
nuclear
transfer
produc
transgen
goat
embryo
subsequ
vitro
differenti
variou
stage
preimplant
develop
confirm
silenc
capac
shrna
brain
tissu
grow
fetu
compar
agematch
normal
fetu
author
observ
approxim
reduct
express
prp
c
howev
clinic
efficaci
reduc
risk
neurodegen
diseas
determin
data
regard
efficaci
present
suggest
techniqu
surpass
major
technic
hurdl
furthermor
two
studi
describ
efficaci
rnai
silenc
fmdv
transgen
bovin
fetal
epithelium
cell
bfec
although
rigor
neg
control
lack
make
difficult
ascrib
effect
transgen
manipul
first
conduct
wang
et
al
describ
construct
three
recombin
lentivir
vector
contain
shrna
fmdv
subsequ
test
silenc
power
cell
vector
transfect
bovin
fetal
fibroblast
cell
stabli
transfect
cell
transfer
enucl
oocyt
reconstruct
embryo
transfer
recipi
cow
shrna
express
transgen
fetus
significantli
degrad
viral
rna
inocul
fmdv
titer
inhibit
viral
replic
thu
primari
transgen
bovin
fetu
tongu
epithelium
cell
becam
much
resist
fmdv
challeng
second
report
shrnaexpress
lentivir
vector
target
fmdv
result
strong
suppress
protein
express
cell
also
significantli
inhibit
viral
replic
cell
construct
transfect
bovin
fetal
fibroblast
cell
clone
somat
cell
result
transgen
fetus
fmdv
rna
synthesi
viral
replic
significantli
reduc
primari
tongu
epitheli
cell
transgen
fetus
suggest
rnai
technolog
potenti
use
gener
transgen
cattl
resist
fmdv
taken
togeth
studi
summar
support
idea
transgen
clone
may
prove
use
tool
deliv
antivir
antiprion
rnai
germ
line
anim
veterinari
import
substanti
addit
work
remain
done
technolog
may
demonstr
efficaci
veterinari
practic
despit
excit
util
noncod
rna
combat
anim
viral
diseas
consider
challeng
still
need
overcom
use
clinic
anim
breeder
tend
rear
flock
larg
group
intens
semiintens
husbandri
larg
farm
would
wast
term
money
time
labor
deliv
expens
molecul
individu
basi
case
veterinarian
prefer
use
antivir
therapi
common
sourc
biovehicl
instanc
food
water
air
ensur
quick
access
think
use
individu
mirnabas
therapi
practic
special
case
follow
race
hors
expens
parent
flock
chicken
turkey
intend
product
specif
pathogenfre
spf
egg
purebr
domest
anim
kept
stock
distribut
semen
artifici
insemin
cross
breed
improv
certain
anim
trait
meat
milk
fat
product
control
contagi
viral
diseas
instanc
fmdv
iav
necessit
rapid
intervent
strategi
prevent
viru
spread
one
farm
anoth
anim
human
regard
rnai
produc
inhibitori
effect
within
day
cell
line
consid
insuffici
rapidli
oper
approach
need
anoth
technic
challeng
excess
level
introduc
mirna
satur
intern
host
process
machin
host
small
rna
give
rise
toxic
patholog
mortal
anim
therapi
therefor
dose
introduc
rnaibas
therapi
well
control
deliveri
rnai
molecul
key
roadblock
whole
process
rnai
molecul
neg
charg
penetr
cell
membran
effect
step
necessari
subsequ
silenc
mrna
cytoplasm
addit
may
quickli
excret
low
stabil
nontissu
specif
may
ineffici
intracellular
releas
although
deliveri
silenc
molecul
may
mediat
via
vector
suboptim
vector
select
might
reduc
silenc
effect
mani
deliveri
system
nanoparticl
cation
lipid
calcium
phosphat
antibodi
cholesterol
viral
vector
test
anoth
perspect
use
singl
rnai
silenc
molecul
low
percent
match
target
mrna
would
lead
poor
target
reduct
possibl
solut
includ
either
appli
one
sirna
ident
sequenc
interest
appli
one
sirna
sequenc
target
differ
conserv
region
target
gene
case
iav
spontan
mutat
estim
occur
rate
approxim
per
nucleotid
per
infect
cycl
suggest
target
sequenc
mismatch
aris
inevit
anoth
challeng
develop
univers
rnai
molecul
sequenc
multipl
influenza
strain
virus
may
evolv
mechan
circumv
target
rnai
molecul
either
express
virusencod
suppressor
mutat
order
avoid
scientist
tri
design
rnai
molecul
simultan
target
sever
sequenc
within
viral
gene
practic
fish
aquacultur
system
rnaibas
therapi
demonstr
limit
rear
system
fish
farm
rear
cage
kept
float
sea
river
water
socal
open
sea
river
cage
aquacultur
system
introduc
rnai
molecul
fish
feed
allow
settlement
uneaten
food
contain
therapi
bottom
water
bodi
would
ineffect
would
also
make
feed
avail
nontarget
organ
thu
altern
improv
approach
would
use
rnai
landbas
pond
tank
owe
direct
access
fish
easi
dispos
wast
materi
commerci
field
applic
inject
therapi
neither
practic
realist
especi
shrimp
rear
intens
system
despit
rel
high
expens
soak
shrimp
solut
contain
rnai
silenc
molecul
practic
way
ensur
effect
suppress
gene
achiev
unfortun
shrimp
cell
line
avail
research
commun
delay
better
understand
rnai
applic
shrimp
farm
effect
design
rnai
molecul
also
special
concern
although
variou
comput
tool
develop
systemat
evalu
target
mirna
sirna
nonspecif
offtarget
effect
need
anticip
mani
paramet
influenc
specif
mirnassirna
includ
select
target
region
size
start
nucleotid
gc
content
thermodynam
properti
introduc
molecul
presenc
intern
repeat
apart
effect
design
use
accur
posit
neg
control
necessari
ensur
valid
rnai
data
evid
gather
thu
far
everi
reason
optimist
futur
use
sncrna
diagnosi
monitor
treatment
anim
viral
diseas
zoonot
virus
continu
pose
public
health
threat
human
mirna
associ
zoonot
viral
diseas
found
conserv
among
human
anim
reservoir
exhibit
similar
tissu
tropism
import
investig
contribut
mirna
zoonot
natur
diseas
potenti
role
biomark
therapeut
tool
human
anim
even
import
viral
diseas
affect
poultri
popul
rear
intens
semiintens
system
pathogen
transmit
short
time
popul
environ
infect
suscept
host
regard
use
rnai
combat
virus
search
target
sequenc
conserv
across
strain
highest
prioriti
studi
target
anim
virus
particular
featur
rapid
genom
chang
iav
rna
virus
howev
use
pool
variou
sirna
cocktail
sirna
specif
viru
host
gene
might
reduc
escap
mutant
virus
addit
would
valuabl
develop
rapidli
act
rnai
technolog
inhibit
spread
highli
contagi
infect
fmd
prospect
incorpor
rnai
molecul
anim
feed
water
suppli
might
practic
choic
treatment
anim
rear
larg
number
fish
poultri
use
strategi
success
experi
record
shrimp
infect
white
spot
syndrom
viru
wssv
spite
extens
effort
toward
formul
suitabl
vehicl
one
deliv
smallest
rnai
quantiti
nontox
way
remain
discov
respect
use
natur
exosom
natur
synthet
highdens
lipoprotein
hdlp
novel
promis
approach
area
research
like
engag
veterinari
scientist
virologist
year
ahead
improv
facilit
use
mirna
sirna
prevent
control
anim
virus
veterinari
clinic
site
field
small
noncod
rna
known
crucial
regul
gene
express
great
potenti
applic
diagnosi
prevent
treatment
figur
respect
deregul
mirna
upon
infect
stabil
tissu
specif
made
studi
biomark
fruit
area
research
sirna
molecul
togeth
mirna
mimic
agonist
deliv
infect
anim
treatment
option
although
current
genet
engin
virusresist
anim
likelihood
exploit
rnai
technolog
includ
mirna
grow
expect
help
attain
aim
bring
molecul
market
remain
challeng
mani
barrier
still
need
overcom
fact
vitro
model
would
enabl
detail
studi
clinic
relev
molecul
howev
experiment
anim
model
infect
natur
host
laboratori
investig
afford
realist
insight
best
way
util
sncrna
improv
anim
health
importantli
develop
animalspecif
databas
contain
experiment
valid
small
rna
molecul
relat
function
analysi
facilit
use
data
futur
research
continu
emerg
zoonot
virus
warrant
effect
collabor
physician
veterinarian
issu
avail
evid
suggest
clinic
use
sncrna
combat
anim
virus
may
possibl
distant
futur
ms
literatur
search
wrote
initi
draft
manuscript
prepar
figur
tabl
fp
oversaw
project
edit
manuscript
includ
final
version
take
respons
integr
data
studi
support
germanegyptian
research
long
term
scholarship
gerl
joint
program
german
academ
exchang
servic
daad
egyptian
ministri
higher
educ
scientif
research
grant
id
ms
ime
helmholtz
associ
initi
person
medicin
fp
